#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14112	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2387	725.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1629	1629	C	911	C,T	909,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23810	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3992	743.9	0	.	n	.	0	T695C	SNP	695	695	T	1263	1263	C	925	C,A,T	921,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23810	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3992	743.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1905	1905	A	1009	A	1009	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23810	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3992	743.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2539	2539	C	798	C,A	796,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23810	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3992	743.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3165	3165	T	836	T,G	835,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23810	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3992	743.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2613	2613	A	740	A,C	738,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	V36A	NONSYN	106	108	GTG	578	580	GCG	186;188;187	G;C;G	186;188;187	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	620	622	CGG	190;187;186	C,G;G;G	189,1;187;186	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	S68L	NONSYN	202	204	TCG	674	676	TTG	149;145;143	T;T;G	149;145;143	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	A90V	NONSYN	268	270	GCG	740	742	GTT	122;121;121	G;T;T	122;121;121	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	I105V	NONSYN	313	315	ATT	785	787	GTT	132;131;133	G;T,A;T	132;130,1;133	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	N125T	NONSYN	373	375	AAT	845	847	ACC	174;173;173	A;C;C	174;173;173	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	R135C	NONSYN	403	405	CGT	875	877	TGT	195;192;192	T,G;G;T	194,1;192;192	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	K151E	NONSYN	451	453	AAA	923	925	GAA	173;171;169	G;A;A	173;171;169	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	926	928	AAC	171;173;175	A;A;C	171;173;175	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	A172T	NONSYN	514	516	GCG	986	988	ACA	153;153;153	A,C;C;A	152,1;153;153	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	A175E	NONSYN	523	525	GCG	995	997	GAA	157;158;156	G;A;A	157;158;156	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	E176T	NONSYN	526	528	GAA	998	1000	ACC	156;159;159	A;C;C	156;159;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1004	1006	GTC	162;160;160	G,C;T;C	161,1;160;160	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1034	1036	ACG	180;179;182	A;C;G	180;179;182	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1070	1072	AAC	161;160;160	A,C;A;C	160,1;160;160	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1130	1132	TTG	145;144;138	T,C;T;G	144,1;144;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1187	1189	ACC	118;119;119	A;C,T;C	118;118,1;119	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1190	1192	GAC	121;121;123	G;A;C,T	121;121;122,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1199	1201	GCG	131;135;135	G;C;G	131;135;135	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1235	1237	GCT	142;142;146	G;C;T	142;142;146	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1562	folP	858	858	91.61	folP.l15.c4.ctg.1	1905	102.2	1	SNP	p	R230S	1	.	.	688	690	AGC	1160	1162	AGC	120;118;117	A;G;C	120;118;117	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4948	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3743	164.8	1	SNP	p	S91F	0	.	.	271	273	TCC	788	790	TCC	182;180;183	T;C;C	182;180;183	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4948	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3743	164.8	1	SNP	p	D95N	0	.	.	283	285	GAC	800	802	GAC	198;194;193	G;A;C,T	198;194;192,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4948	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3743	164.8	1	SNP	p	D95G	0	.	.	283	285	GAC	800	802	GAC	198;194;193	G;A;C,T	198;194;192,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1930	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1811	133.0	1	SNP	p	G45D	1	.	.	133	135	GAC	702	704	GAC	215;216;214	G;A;C	215;216;214	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1070	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1524	87.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3341	180.5	1	SNP	p	D86N	0	.	.	256	258	GAC	748	750	GAC	202;205;206	G,C;A;C	201,1;205;206	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3341	180.5	1	SNP	p	S87W	0	.	.	259	261	AGT	751	753	AGT	207;206;206	A;G;T,G	207;206;205,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3341	180.5	1	SNP	p	S87I	0	.	.	259	261	AGT	751	753	AGT	207;206;206	A;G;T,G	207;206;205,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3341	180.5	1	SNP	p	S87R	0	.	.	259	261	AGT	751	753	AGT	207;206;206	A;G;T,G	207;206;205,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4836	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3341	180.5	1	SNP	p	S88P	0	.	.	262	264	TCC	754	756	TCC	209;207;210	T;C;C	209;207;210	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4092	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3025	168.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1704	1706	GGC	219;217;213	G;G;C	219;217;213	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1490	1492	GCA	226;230;228	G,T;C;A	225,1;230;228	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1493	1495	ATC	229;228;229	A;T;C,A	229;228;228,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1505	1507	GTG	228;230;234	G;T;G	228;230;234	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1505	1507	GTG	228;230;234	G;T;G	228;230;234	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2009	2011	ACC	200;202;200	A;C;C,G	200;202;199,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2063	2065	GCG	179;179;179	G;C;G	179;179;179	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2063	2065	GCG	179;179;179	G;C;G	179;179;179	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2186	2188	GGC	227;226;226	G;G;C,A	227;226;225,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2195	2197	GGC	228;229;230	G,A;G,T;C,A	227,1;228,1;229,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3760	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	165.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2213	2215	CCG	221;223;224	C,A;C;G	220,1;223;224	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5160	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3471	185.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2316	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2238	129.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	794	794	C	136	C,G	135,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	G38E	NONSYN	112	114	GGA	492	494	GAA	246;246;246	G;A;A,C	246;246;245,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	522	524	GGA	261;262;261	G;G;A	261;262;261	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	T87A	NONSYN	259	261	ACT	639	641	GCT	228;227;229	G;C;T,G	228;227;228,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	645	647	AGC	221;221;221	A;G;C	221;221;221	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	737	738	CG	230;230	C;G	230;230	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	740	742	CAG	231;232;229	C;A,G;G	231;231,1;229	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	744	746	AAA	225;223;222	A,C,G;A;A,T,C	223,1,1;223;220,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	807	809	GAA	214;215;216	G;A;A	214;215;216	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	831	833	GCA	216;212;211	G,A;C;A	215,1;212;211	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1014	1016	GAT	250;248;250	G;A;T	250;248;250	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1017	1019	GGT	245;246;245	G;G;T	245;246;245	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1032	1034	ATG	240;242;243	A,G;T;G	239,1;242;243	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1146	1148	GCA	203;200;199	G;C;A	203;200;199	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1149	1151	ACG	197;199;200	A,C;C,G;G	196,1;198,1;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1152	1154	GGG	199;200;202	G,T;G;G,C,A	198,1;200;200,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1155	1157	GTT	198;196;196	G;T;T,G	198;196;195,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1215	1217	GTA	218;220;220	G;T,A;A	218;219,1;220	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1254	1256	ACT	242;243;243	A;C;T	242;243;243	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1260	1262	GAT	242;244;243	G;A;T	242;244;243	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1272	1274	CAC	256;257;259	C,G,A;A;C,T	254,1,1;257;258,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	1	SNP	p	G120K	1	.	.	358	360	AAG	737	739	CGG	230;230;228	C;G;G	230;230;228	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	1	SNP	p	A121D	1	.	.	361	363	GAC	740	743	CGC	231;229;227	C;G;C,A	231;229;226,1	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2748	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1576	212.2	1	SNP	p	D121N	0	.	.	361	363	GAC	740	743	CGC	231;229;227	C;G;C,A	231;229;226,1	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9684	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5418	223.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2215	2217	CAT	266;263;264	C;A;T	266;263;264	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1340	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1485	112.3	1	SNP	p	V57M	1	.	.	169	171	ATG	701	703	ATG	254;252;249	A;T;G	254;252;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
